Royal Bank of Canada restated their outperform rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a report released on Wednesday morning,Benzinga reports. The firm currently has ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

Fintel reports that on January 16, 2025, UBS downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Buy ...

Wall Street is suddenly uneasy about Trump's agenda, and the markets are sending him a message ...

Fintel reports that on January 17, 2025, UBS downgraded their outlook for Charles River Laboratories International (NYSE:CRL) ...

In pharmaceuticals and biotech ... Former BlackRock executive Salim Ramji succeeded Tim Buckley as Vanguard’s fifth chief executive officer on July 8, 2024. Ramji left BlackRock in January ...

The Pharmacy Council of Nigeria, PCN, Thursday, reiterated its warning to pharmacists against engaging in ethical misconduct, ...

Biotech has lagged even more. The S&P Biotechnology Select Industry Index has returned about 3 per cent annually over 10 ...

By Moses Ochonu It was a typical summer day in July 2023, but little did anyone know that a new chapter was about to unfold ...

Despite the serious risks of drinking it, a growing movement — including the potential health secretary Robert F. Kennedy Jr.

Pleased that London is in the vanguard of providing an actual solution to the problem of obesity? As a nation the UK – self ...

Wealth Enhancement Advisory Services LLC boosted its holdings in Premier, Inc. (NASDAQ:PINC – Free Report) by 34.1% in the ...